237 related articles for article (PubMed ID: 16226079)
1. Short QT syndrome. Genotype-phenotype correlations.
Borggrefe M; Wolpert C; Antzelevitch C; Veltmann C; Giustetto C; Gaita F; Schimpf R
J Electrocardiol; 2005 Oct; 38(4 Suppl):75-80. PubMed ID: 16226079
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and treatment of short QT syndrome.
Wolpert C; Schimpf R; Veltmann C; Giustetto C; Gaita F; Borggrefe M
Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):611-7. PubMed ID: 16076272
[TBL] [Abstract][Full Text] [Related]
3. Short QT syndrome.
Schimpf R; Wolpert C; Gaita F; Giustetto C; Borggrefe M
Cardiovasc Res; 2005 Aug; 67(3):357-66. PubMed ID: 15890322
[TBL] [Abstract][Full Text] [Related]
4. Short QT syndrome: pharmacological treatment.
Gaita F; Giustetto C; Bianchi F; Schimpf R; Haissaguerre M; Calò L; Brugada R; Antzelevitch C; Borggrefe M; Wolpert C
J Am Coll Cardiol; 2004 Apr; 43(8):1494-9. PubMed ID: 15093889
[TBL] [Abstract][Full Text] [Related]
5. Clinical and molecular genetics of the short QT syndrome.
Schimpf R; Borggrefe M; Wolpert C
Curr Opin Cardiol; 2008 May; 23(3):192-8. PubMed ID: 18382206
[TBL] [Abstract][Full Text] [Related]
6. Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibility.
Odening KE; Bodi I; Franke G; Rieke R; Ryan de Medeiros A; Perez-Feliz S; Fürniss H; Mettke L; Michaelides K; Lang CN; Steinfurt J; Pantulu ND; Ziupa D; Menza M; Zehender M; Bugger H; Peyronnet R; Behrends JC; Doleschall Z; Zur Hausen A; Bode C; Jolivet G; Brunner M
Eur Heart J; 2019 Mar; 40(10):842-853. PubMed ID: 30496390
[TBL] [Abstract][Full Text] [Related]
7. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
8. [Short QT syndrome].
Wolpert C; Schimpf R; Veltmann C; Borggrefe M
Herz; 2007 May; 32(3):206-10. PubMed ID: 17497253
[TBL] [Abstract][Full Text] [Related]
9. Short QT syndrome. Update on a recent entity.
Maury P; Extramiana F; Sbragia P; Giustetto C; Schimpf R; Duparc A; Wolpert C; Denjoy I; Delay M; Borggrefe M; Gaita F
Arch Cardiovasc Dis; 2008; 101(11-12):779-86. PubMed ID: 19059573
[TBL] [Abstract][Full Text] [Related]
10. [Short QT Syndromes].
Schulze-Bahr E
Herz; 2006 Apr; 31(2):118-22; quiz 142-3. PubMed ID: 16738834
[TBL] [Abstract][Full Text] [Related]
11. In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome: a pilot study.
Schimpf R; Veltmann C; Giustetto C; Gaita F; Borggrefe M; Wolpert C
J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1157-60. PubMed ID: 17711440
[TBL] [Abstract][Full Text] [Related]
12. [Familial short QT syndrome].
Lupoqlazoff JM; Denjoy I
Rev Prat; 2007 Jan; 57(2):121-5. PubMed ID: 17432514
[TBL] [Abstract][Full Text] [Related]
13. Short QT syndrome: a review.
Patel U; Pavri BB
Cardiol Rev; 2009; 17(6):300-3. PubMed ID: 19829181
[TBL] [Abstract][Full Text] [Related]
14. Short QT syndrome: a very rare arrhythmogenic entity.
Yontar OC; Yalta K; Yilmaz MB; Turgut OO
Acta Cardiol; 2008 Oct; 63(5):553-5. PubMed ID: 19013996
[TBL] [Abstract][Full Text] [Related]
15. In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.
Luo C; Wang K; Zhang H
PLoS One; 2017; 12(6):e0179515. PubMed ID: 28632743
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome.
Kaufman ES
Heart Rhythm; 2009 Aug; 6(8 Suppl):S51-5. PubMed ID: 19631908
[TBL] [Abstract][Full Text] [Related]
17. Congenital short QT syndrome: landmarks of the newest arrhythmogenic cardiac channelopathy.
Pérez Riera AR; Paixão-Almeida A; Barbosa-Barros R; Yanowitz FG; Baranchuk A; Dubner S; Palandri Chagas AC
Cardiol J; 2013; 20(5):464-71. PubMed ID: 23677719
[TBL] [Abstract][Full Text] [Related]
18. Short QT syndrome: a case report and review of literature.
Lu LX; Zhou W; Zhang X; Cao Q; Yu K; Zhu C
Resuscitation; 2006 Oct; 71(1):115-21. PubMed ID: 16942825
[TBL] [Abstract][Full Text] [Related]
19. A novel mutation in the KCNH2 gene associated with short QT syndrome.
Sun Y; Quan XQ; Fromme S; Cox RH; Zhang P; Zhang L; Guo D; Guo J; Patel C; Kowey PR; Yan GX
J Mol Cell Cardiol; 2011 Mar; 50(3):433-41. PubMed ID: 21130771
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of patients with short QT syndrome.
Giustetto C; Schimpf R; Mazzanti A; Scrocco C; Maury P; Anttonen O; Probst V; Blanc JJ; Sbragia P; Dalmasso P; Borggrefe M; Gaita F
J Am Coll Cardiol; 2011 Aug; 58(6):587-95. PubMed ID: 21798421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
